HKUMed research team identifies new drug combo for liver cancer via CRISPR-Cas9 screen. The research team includes (from left): Dr Stephanie Ma, Associate Professor; Dr Xu Feng, Post-doctoral Fellow; Dr Carol Tong Man, Research Assistant Professor and Dr Alan Wong Siu-lun, Assistant Professor, School of Biomedical Sciences, HKUMed. (IMAGE)

The University of Hong Kong

HKUMed research team identifies new drug combo for liver cancer via CRISPR-Cas9 screen. The research team includes (from left): Dr Stephanie Ma, Associate Professor; Dr Xu Feng, Post-doctoral Fellow; Dr Carol Tong Man, Research Assistant Professor and Dr Alan Wong Siu-lun, Assistant Professor, School of Biomedical Sciences, HKUMed.

Caption

HKUMed research team identifies new drug combo for liver cancer via CRISPR-Cas9 screen. The research team includes (from left): Dr Stephanie Ma, Associate Professor; Dr Xu Feng, Post-doctoral Fellow; Dr Carol Tong Man, Research Assistant Professor and Dr Alan Wong Siu-lun, Assistant Professor, School of Biomedical Sciences, HKUMed.

Credit

The University of Hong Kong

Usage Restrictions

This work is licensed for non-commercial, non-exclusive, one-time usage with attribution to the copyright holder.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.